期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL INFECTIOUS DISEASES LetPub Score 9.2
50 ratings
Rate
Reputation 10.0 Influence 8.5 Speed 9.7 | |||||||||||||||||||||
期刊簡稱 | CLIN INFECT DIS | |||||||||||||||||||||
ISSN | 1058-4838 | |||||||||||||||||||||
E-ISSN | 1537-6591 | |||||||||||||||||||||
h-index | 303 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 3.70%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | https://academic.oup.com/cid | |||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CID | |||||||||||||||||||||
開放訪問 | No | |||||||||||||||||||||
出版商 | Oxford University Press | |||||||||||||||||||||
主題領域 | 医学 | |||||||||||||||||||||
出版國/地區 | UNITED STATES | |||||||||||||||||||||
發行頻率 | 月2回刊行 | |||||||||||||||||||||
創刊年 | 1992 | |||||||||||||||||||||
每年文章數 | 523每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 44.97% | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1058-4838%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) | |||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[CLINICAL INFECTIOUS DISEASES] 的評論 | 撰寫評論 |
作者: 两仪弘扬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-29 16:45:17 評論於 Is the article you wrote a clinical article?(0) 讚! | 两仪弘扬 |
作者: youxingshao 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-05-06 17:30:27 評論於 Not ASM, it's IDSA.(0) 讚! | youxingshao |
作者: 珉林海荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-16 08:04:55 評論於 Can you tell me what the final result is?(0) 讚! | 珉林海荣 |
作者: 长安笑真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-15 20:03:16 評論於 I want to ask if the "under review" status of this submission system means it is under review(0) 讚! | 长安笑真 |
作者: 长安笑真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-08 19:45:27 評論於 I want to ask if "undereview" means it has been submitted. It has been "undereview" for 8 days already(0) 讚! | 长安笑真 |
作者: 水月高歌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-22 09:57:44 評論於 Hello, did you end up rejecting it directly?(0) 讚! | 水月高歌 |
作者: 光远公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-27 21:21:59 評論於 Review Speed: 6.0 | Submission Success Rate: 25.0 Experience Sharing: Submitted at the end of October, received minor revisions in early January of the next year. The two reviewers were very professional, asking many questions about their interests in addition to revision suggestions. Accepted after a month and a half of revisions, and the original manuscript was published online a week later. The formatting stage took a long time, and the official version was not published online until two to three months later. Originally ranked third in infectious disease journals, but due to the large number of articles on COVID-19, other well-established infectious disease journals have expanded significantly, and it is now ranked sixth. Nonetheless, it remains a renowned journal in the field of infectious diseases(0) 讚! | 光远公子 |
作者: Mortimer Beard 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-17 21:00:34 評論於 Just submitted and it already changed to "decision in process", but it has been 4 days and still no news. Senior, what does this mean? Is the editor still deciding whether to send it for review?(0) 讚! | Mortimer Beard |
作者: 玄虚荣荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-20 10:55:27 評論於 I would like to ask, what area does your submission focus on?(0) 讚! | 玄虚荣荣 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:39:14 評論於 There are many factors that can affect the efficacy of animal experiments or clinical treatments. Unless the results obtained are significantly greater than the sum of the effectiveness of each drug, it can be clearly determined that a synergistic effect has been achieved, otherwise it is generally referred to as an additive effect(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:52:32 評論於 The requirement to upload according to the guidelines of the authors of the journal(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 15:26:31 評論於 How to determine whether the interaction between two drugs is synergistic or additive?(0) 讚! | 上清雨真 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:09:32 評論於 What are the requirements for uploading articles?(0) 讚! | Darlene Pepys |
作者: 重阳承嗣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 13:58:41 評論於 Awesome(0) 讚! | 重阳承嗣 |
作者: Ellis Acheson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-24 20:24:52 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Research focus: Infectious diseases; Tuberculosis Experience sharing: Submitted in August, received review comments in one month, allowed two months for major revisions, both reviewers' feedback was very positive and there were not many issues raised. Accepted for publication the day after minor revisions were submitted(0) 讚! | Ellis Acheson |
作者: 深渊初霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-16 08:04:55 評論於 Please translate the following passage into English and Japanese, and title them "" and ""(0) 讚! | 深渊初霜 |
作者: 南风柔谨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-05 21:10:15 評論於 Just rearrange the order(0) 讚! | 南风柔谨 |
作者: 德华姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-02 21:27:19 評論於 Should I still do not have it, can you send me the link so I can see which one it is?(0) 讚! | 德华姑娘 |
作者: Virgil 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-16 10:04:03 評論於 Is it working now? I can see articles with mutual communication(0) 讚! | Virgil |
作者: 葵花雅宁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-24 09:16:08 評論於 Can a journal have two first authors? If the journal lists the corresponding author first, how can we show who the first author is? Can there only be one corresponding author? Please enlighten me, thank you!(0) 讚! | 葵花雅宁 |
作者: 德华姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-02 23:28:02 評論於 cid and jid are both required for this request. Only one communication channel is allowed(0) 讚! | 德华姑娘 |
作者: 上清平松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-16 23:45:34 評論於 The article on the unit's research on the new coronavirus feels very efficient(0) 讚! | 上清平松 |
作者: 黑山栾诺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-15 08:22:51 評論於 Please translate the following passage into English and Japanese, and title them as ":" and "(0) 讚! | 黑山栾诺 |
作者: 努力啊大岚风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-08 13:55:19 評論於 Which journal are you talking about? ifmorethanten published on 2016-10-13: SCI(2015): 8.736, SCI(2014): 8.886. This journal only allows one corresponding author, so please be careful when submitting collaborative articles from multiple research teams. Do not cause trouble(0) 讚! | 努力啊大岚风 |
作者: 菩提嘉木 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-02 15:13:34 評論於 Can you accept the case? Just wondering(0) 讚! | 菩提嘉木 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us